ERSTE STOCK BIOTEC CZK R01 (VTA)/ AT0000A0XYP0 /
| NAV04/11/2024 | Var.+69.0400 | Type of yield | Focus sugli investimenti | Società d'investimento |
|---|---|---|---|---|
| 13,968.1201CZK | +0.50% | Full reinvestment | Equity Sector Biotechnology | Erste AM ▶ |
Performance mensile
| gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 6.06 | 4.16 | 10.68 | 6.33 | 6.48 | -3.18 | 9.10 | -0.85 | 5.31 | -3.70 | 14.90 | -0.11 | +68.77% |
| 2014 | 12.51 | 7.09 | -15.75 | -0.83 | 6.52 | 6.14 | 2.72 | 10.21 | 3.08 | 8.36 | 2.83 | 4.26 | +54.28% |
| 2015 | 13.35 | 6.10 | 6.20 | -5.52 | 8.29 | -3.77 | 6.63 | -8.60 | -17.49 | 15.60 | 7.12 | -3.47 | +20.88% |
| 2016 | -26.81 | -0.46 | -5.58 | 9.99 | 2.48 | -7.17 | 12.53 | -2.01 | 3.27 | -6.46 | 11.85 | -5.24 | -18.75% |
| 2017 | 0.76 | 10.07 | -1.92 | 0.03 | -9.50 | 6.57 | 0.61 | -0.21 | 3.38 | -5.11 | -3.78 | 4.84 | +4.26% |
| 2018 | 1.06 | -2.65 | -3.71 | 1.49 | 9.13 | 2.51 | 1.78 | 8.83 | -1.35 | -13.87 | 3.63 | -12.89 | -8.63% |
| 2019 | 17.96 | 8.95 | -4.32 | -1.15 | -3.39 | 2.85 | 2.67 | -4.75 | -5.49 | 4.67 | 12.57 | 0.51 | +32.21% |
| 2020 | -4.95 | -3.10 | 1.79 | 13.10 | 3.35 | -0.76 | -6.21 | -5.86 | 5.55 | 1.10 | -3.74 | 2.42 | +1.02% |
| 2021 | 2.95 | -2.57 | -3.18 | -1.71 | -5.90 | 8.49 | -2.10 | 4.33 | -3.20 | -0.62 | -2.47 | -1.83 | -8.33% |
| 2022 | -12.69 | -0.85 | 3.92 | -0.32 | -4.16 | 3.20 | 5.87 | 0.71 | 2.08 | 5.49 | -2.64 | -3.90 | -4.73% |
| 2023 | -1.17 | -3.04 | -2.68 | 1.25 | 1.37 | -1.55 | 1.30 | 1.65 | -0.01 | -6.19 | -0.99 | 15.10 | +3.72% |
| 2024 | 1.73 | 6.29 | -2.90 | -6.30 | -1.42 | 9.89 | 6.49 | -2.53 | -4.84 | 3.89 | 0.50 | - | - |
Calculated values
| YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
|---|---|---|---|---|---|
| Volatilità | 16.08% | 15.15% | 17.34% | 21.19% | 24.02% |
| Indice di Sharpe | 0.55 | 1.02 | 1.05 | -0.14 | -0.03 |
| Mese migliore | +15.10% | +9.89% | +15.10% | +15.10% | +15.10% |
| Mese peggiore | -6.30% | -4.84% | -6.30% | -12.69% | -12.69% |
| Perdita massima | -11.78% | -7.91% | -11.78% | -26.41% | -35.30% |
| Outperformance | -1.94% | - | -7.59% | -30.56% | -29.75% |
Tutte le quotazioni in CZK
Tranches
| Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
|---|---|---|---|---|---|
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 3,192.5400 | +21.28% | +0.30% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 53,787.4219 | +26.54% | +17.63% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 128.9400 | +17.49% | +1.83% | |
| ERSTE Stock Biotec D01 A | paying dividend | 125.7300 | +16.93% | +1.18% | |
| ERSTE Stock Biotec D01 T | reinvestment | 124.7400 | +16.93% | +1.18% | |
| ERSTE STOCK BIOTEC EUR R01 (VTA) | Full reinvestment | 552.2100 | +16.91% | +1.16% | |
| ERSTE STOCK BIOTEC HUF R01 (VTA) | Full reinvestment | 225,189.9531 | +25.88% | +14.88% | |
| ERSTE STOCK BIOTEC CZK R01 (VTA) | Full reinvestment | 13,968.1201 | +21.22% | +0.20% | |
| ERSTE STOCK BIOTEC EUR R01 (A) | paying dividend | 503.0400 | +16.93% | +1.18% | |
| ERSTE STOCK BIOTEC EUR R01 (T) | reinvestment | 503.0200 | +16.93% | +1.18% |
Prestazione
| YTD | +9.89% | ||
|---|---|---|---|
| 6 mesi | +8.84% | ||
| 1 anno | +21.22% | ||
| 3 anni | +0.20% | ||
| 5 anni | +11.84% | ||
| 10 anni | +32.11% | ||
| Dall'inizio | +212.00% | ||
| Anno | |||
| 2023 | +3.72% | ||
| 2022 | -4.73% | ||
| 2021 | -8.33% | ||
| 2020 | +1.02% | ||
| 2019 | +32.21% | ||
| 2018 | -8.63% | ||
| 2017 | +4.26% | ||
| 2016 | -18.75% | ||
| 2015 | +20.88% | ||
